Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
United States
Duke Cancer Institute, Durham, North Carolina Baylor St Lukes, Houston, Texas Last updated September 2025